104 studies found for:    new onset type 1 diabetes
Show Display Options
RSS Create an RSS feed from your search for:
new onset type 1 diabetes
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting New Onset Type 1 Diabetes: Role of Exenatide
Conditions: Type 1 Diabetes;   New Onset Type 1 Diabetes
Interventions: Drug: Exenatide;   Drug: Rapid and long acting insulin;   Drug: long acting insulin + rapid acting + 1.25 mcg Exenatide
2 Terminated
Has Results
Study of Antithymocyte Globulin for Treatment of New-onset T1DM
Condition: New-onset Type 1 Diabetes Mellitus
Interventions: Drug: Antithymocyte globulin;   Drug: Placebo
3 Recruiting Phase II-III Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes
Condition: New Onset Type-1 Diabetes
Interventions: Biological: Alpha-1 Antitrypsin;   Other: Placebo
4 Completed Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: pioglitazone;   Drug: Placebo control
5 Completed Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: otelixizumab infusion plus physician determined standard of care;   Biological: placebo infusion plus physician determined standard of care
6 Completed A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: NBI-6024
7 Recruiting Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: 180 mg/kg Alpha1-PI;   Biological: 90 mg/kg Alpha1-PI;   Biological: Placebo
8 Recruiting Efficacy and Safety Study of Autologous Hematopoietic Stem Cell Transplantation to Treat New Onset Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Procedure: immunosuppression and stem cell transplantation
9 Terminated
Has Results
Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes
Conditions: Diabetes Mellitus Type 1;   Autoimmune Diabetes
Interventions: Drug: Insulin;   Drug: Lansoprazole;   Drug: Sitagliptin;   Biological: Diamyd;   Drug: GAD65 (Diamyd)
10 Completed Use of a Telehomecare Program for Young Patients With New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Device: Telehomecare (Intelligent Distance Patient Monitoring);   Other: Standard education and follow up at diabetes clinic
11 Withdrawn Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: efalizumab;   Drug: placebo
12 Completed Immunointervention With Calcitriol in New-Onset Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: 1,25-dihydroxy-vitamin D3 (calcitriol);   Drug: placebo
13 Recruiting Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus
Conditions: Type 1 Diabetes;   Insulin Dependent Diabetes;   Juvenile Onset Diabetes Mellitus;   Autoimmune Diabetes
Intervention: Drug: Vildagliptin
14 Completed Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Otelixizumab;   Biological: Placebo
15 Completed Anti-Interleukin-1 in Diabetes Action
Condition: Type 1 Diabetes
Interventions: Drug: anakinra;   Drug: saline
16 Completed Etanercept in New Onset Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Etanercept;   Drug: Placebo
17 Unknown  New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Mycophenolate mofeteil (MMF);   Drug: Daclizumab (DZB)
18 Not yet recruiting Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D
Condition: Type 1 Diabetes
Intervention: Drug: Ustekinumab
19 Completed Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: CTLA-4 Ig;   Other: Placebo
20 Completed A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Twice Daily versus Three Times Daily Insulin Injections

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years